AI article
Mind-altering substances are (still) falling short in clinical trials
This week I want to look at where we are with psychedelics, the mind-altering substances that have somehow made the leap from counterculture to major focus o...
MIT Technology Review | Mar 20, 2026 | Jessica Hamzelou